A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers Co-Administered the Medicine Rosuvastatin

A Phase 1, Randomized, Fixed Sequence, Multiple-Dose, Open-Label Study to Estimate the Effect of Nirmatrelvir (PF-07321332)/Ritonavir on Rosuvastatin Pharmacokinetics in Healthy Adult Participants

Category & Conditions: Coronavirus Disease (COVID-19)

Medicine: PAXLOVID

ClinicalTrials.gov Identifier (NCT): NCT05898672

Protocol ID: C4671052

Print Download

Open Plain Language Summary Result: Click here